Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: OPKO Health, Inc.

Market Cap 1.08B 935M 858M 807M 1.5B 103B 1.53B 10.2B 3.97B 49.76B 4.05B 3.97B 173B P/E ratio 2026 *
-4.68x
P/E ratio 2027 * -5.42x
Enterprise value 690M 597M 548M 516M 960M 65.72B 975M 6.51B 2.54B 31.78B 2.59B 2.53B 111B EV / Sales 2026 *
1.28x
EV / Sales 2027 * 0.62x
Free-Float
48.6%
Yield 2026 *
-
Yield 2027 * -
1 day-0.69%
1 week+2.14%
Current month-2.05%
1 month+25.44%
3 months+21.19%
6 months+8.33%
Current year+13.49%
1 week 1.37
Extreme 1.37
1.55
1 month 1.08
Extreme 1.075
1.55
Current year 0.98
Extreme 0.9769
1.55
1 year 0.98
Extreme 0.9769
1.6
3 years 0.85
Extreme 0.8516
2.24
5 years 0.85
Extreme 0.8516
5.25
10 years 0.85
Extreme 0.8516
12.15
Manager TitleAgeSince
Chief Executive Officer 88 2007-03-26
President 74 2022-05-08
Director of Finance/CFO 47 2014-03-30
Director TitleAgeSince
Chairman 88 2007-03-26
Director/Board Member 91 2003-11-30
Director/Board Member 65 2007-01-31
Date Insider Type Main position Quantity % Market Cap.
Mar. 19Buy

Director

10,000 0.0013%
Mar. 17Free

Director

50,000 0.0065%
Mar. 17Other

Director

3,158,817 0.4115%
Change 5-day change 1-year change 3-year change Capi.($)
-0.69%+2.14%+5.15%-11.73% 1.08B
-0.85%-2.44%+30.36%+337.26% 30.57B
-1.18%+2.00%+3.17%+18.70% 21.48B
+2.12%+5.56%-25.86%-43.47% 6.76B
-0.33%+2.40%-7.66%+71.07% 4.26B
+1.93%+0.95%+9.63%+61.15% 2.71B
-2.54%-10.20%-21.97%-66.81% 1.6B
-0.95%-4.57%+11.78%-3.70% 1.55B
-0.79%-0.38%-28.13%+673.13% 1.54B
-3.39%-10.67%+8.77%-33.62% 1.47B
Average -0.37%-2.08%-1.48%+100.20% 7.3B
Weighted average by Cap. +0.61%-0.89%+10.59%+160.90%

Financials

2026 *2027 *
Net sales 538M 466M 427M 402M 749M 51.25B 761M 5.08B 1.98B 24.79B 2.02B 1.98B 86.2B 568M 492M 451M 424M 790M 54.1B 803M 5.36B 2.09B 26.16B 2.13B 2.09B 90.98B
Net income -229M -199M -182M -171M -319M -21.85B -324M -2.17B -843M -10.57B -861M -842M -36.74B -195M -169M -155M -146M -272M -18.59B -276M -1.84B -717M -8.99B -732M -716M -31.26B
Net Debt -390M -338M -310M -292M -543M -37.18B -552M -3.68B -1.43B -17.98B -1.46B -1.43B -62.52B -728M -631M -579M -544M -1.01B -69.4B -1.03B -6.88B -2.68B -33.56B -2.73B -2.67B -117B
Logo OPKO Health, Inc.
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Employees
2,275
Date Price Change Volume
26-06-08 1.430 $ -0.69% 1,938,168
26-06-05 1.440 $ -1.37% 3,947,919
26-06-04 1.460 $ 0.00% 2,625,464
26-06-03 1.460 $ +4.29% 4,752,571
26-06-02 1.400 $ 0.00% 3,435,644
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
1.430USD
Average target price
3.760USD
Spread / Average Target
+162.94%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW